48
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Real-Time Methylomic Aberrations During Initiation and Progression of Induced Human Mammary Epithelial Cell Tumorigenesis

, , , &
Pages 155-165 | Published online: 08 Apr 2013

References

  • DeSantis C , SiegelR, BandiP, JemalA. Breast cancer statistics, 2011. CA Cancer J. Clin.61(6) , 409–418 (2011).
  • Hahn WC , CounterCM, LundbergAS, BeijersbergenRL, BrooksMW, WeinbergRA. Creation of human tumour cells with defined genetic elements. Nature400(6743) , 464–468 (1999).
  • Casillas MA , BrothertonSL, AndrewsLG, RuppertJM, TollefsbolTO. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene316 , 57–65 (2003).
  • Liu J , YangG, Thompson-LanzaJA et al. A genetically defined model for human ovarian cancer. Cancer Res. 64(5) , 1655–1663 (2004).
  • Elenbaas B , SpirioL, KoernerF et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15(1) , 50–65 (2001).
  • DeAngelis JT , LiY, MitchellN, WilsonL, KimH, TollefsbolTO. 2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells. J. Proteome Res.10(2) , 447–458 (2011).
  • Katto J , MahlknechtU. Epigenetic regulation of cellular adhesion in cancer. Carcinogenesis32(10) , 1414–1418 (2011).
  • Baylin SB , JonesPA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer11(10) , 726–734 (2011).
  • Doi A , ParkIH, WenB et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41(12) , 1350–1353 (2009).
  • Irizarry RA , Ladd-AcostaC, WenB et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41(2) , 178–186 (2009).
  • Anderson RM , BoschJA, GollMG et al. Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev. Biol. 334(1) , 213–223 (2009).
  • Herman JG , BaylinSB. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med.349(21) , 2042–2054 (2003).
  • Bibikova M , LeJ, BarnesB et al. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 1(1) , 177–200 (2009).
  • Sun Z , ChaiHS, WuY et al. Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med. Genomics 4 , 84 (2011).
  • Storey JD , TibshiraniR. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA100(16) , 9440–9445 (2003).
  • Rajendram R , FerreiraJC, GrafodatskayaD et al. Assessment of methylation level prediction accuracy in methyl-DNA immunoprecipitation and sodium bisulfite based microarray platforms. Epigenetics 6(4) , 410–415 (2011).
  • Hanna CW , BloomMS, RobinsonWP et al. DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum. Reprod. 27(5) , 1401–1410 (2012).
  • Shen J , WangS, ZhangYJ et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 55(6) , 1799–1808 (2012).
  • Esteller M . Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet.8(4) , 286–298 (2007).
  • Holliday R . Epigenetics: a historical overview. Epigenetics1(2) , 76–80 (2006).
  • Herman JG , MerloA, MaoL et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55(20) , 4525–4530 (1995).
  • Jones PA , BaylinSB. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet.3(6) , 415–428 (2002).
  • Bernardino J , RouxC, AlmeidaA et al. DNA hypomethylation in breast cancer: an independent parameter of tumor progression? Cancer Genet. Cytogenet. 97(2) , 83–89 (1997).
  • Soares J , PintoAE, CunhaCV et al. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer 85(1) , 112–118 (1999).
  • Veeck J , EstellerM. Breast cancer epigenetics: from DNA methylation to microRNAs. J. Mammary Gland Biol. Neoplasia15(1) , 5–17 (2010).
  • Ruike Y , ImanakaY, SatoF et al. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11 , 137 (2010).
  • Fackler MJ , UmbrichtCB, WilliamsD et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 71(19) , 6195–6207 (2011).
  • Tan J , GuY, ZhangX et al. Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis. Clin. Exp. Med. 13(1) , 1–9 (2012).
  • Park SY , KwonHJ, LeeHE et al. Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch. 458(1) , 73–84 (2011).
  • Alvarez H , OpalinskaJ, ZhouL et al. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 7(3) , e1001356 (2011).
  • Rauch T , WangZ, ZhangX et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc. Natl Acad. Sci. USA 104(13) , 5527–5532 (2007).
  • Novak P , JensenT, OshiroMM et al. Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res. 66(22) , 10664–10670 (2006).
  • Helman E , NaxerovaK, KohaneIS. DNA hypermethylation in lung cancer is targeted at differentiation-associated genes. Oncogene31(9) , 1181–1188 (2012).
  • van Vlodrop IJ , NiessenHE, DerksS et al. Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin. Cancer Res. 17(13) , 4225–4231 (2011).
  • Easwaran H , JohnstoneS, VannesteL et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res. 22(5) , 837–849 (2012).
  • Mohammad HP , CaiY, McGarveyKM et al. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res. 69(15) , 6322–6330 (2009).
  • Viré E , BrennerC, DeplusR et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439(7078) , 871–874 (2006).
  • Ben-Porath I , ThomsonMW, CareyVJ et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40(5) , 499–507 (2008).
  • Lee TI , JennerRG, BoyerLA et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125(2) , 301–313 (2006).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.